While Solana continues to show strength and may realistically hit $300 early next year, analysts agree that the largest ...

More companies are intensifying overseas expansion efforts after a better-than-expected 2025, driven by diversification and ...

Glen Finegan explains why emerging markets offer better value than stretched developed markets, and how to avoid the ...

Read the latest insights on Manhattan Associates’ stock—analysis of growth prospects, financial health, and key risks for ...

“Cosmetics that retailers and salons in Washington received in 2025 should already meet the new restrictions in the law, but older stock might not,” Franjevic said. “The close of the sell-through ...

Beef prices may drop but consumers face "slow and painful" wait for relief, warns a Wells Fargo economist. Cattle shortages ...

A storm is brewing around China’s AI upstart DeepSeek amid claims it used smuggled Nvidia Blackwell GPUs banned from export ...

Chinese rare-earth magnet suppliers to U.S. automaker Ford Motor were included in the first batch of new export licences ...

Discover why Samsara (IOT) is a strong buy—robust ARR growth, elite retention metrics, and high EPS projections promise ...

FDA grants 1st approval under priority voucher program to Augmentin XR, expediting review and supporting U.S. antibiotic supply chain resilience.

GEP’s newest volatility index shows spare capacity widening across global supply chains — with North America seeing the ...

Nvidia remains the dominant AI chipmaker in the market, but where is the stock headed for the rest of this year and into the next?